Interplay of genes regulated by estrogen and diindotylmethane in breast cancer cell lines

Molecular Medicine

Volumn 13, Issue 1-2, 2007, Pages 69-78

  Mulvey, Laura ^a   Chandrasekaran, Alamelu ^a   Liu, Kai ^a   Lombardi, Sarah ^a   Wang, Xue Ping ^a   Auborn, Karen J ^a,b   Goodwin, Leslie ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; DIINDOLYLMETHANE; ESTRADIOL; ESTROGEN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER THERAPY; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG INTERACTIONS; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOLES; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 34249099665     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2006-00038.Mulvey     Document Type: Article

References (49)

1. Ge X, Fares FA, Yannai S. 1999. Induction of apoptosis in MCF-7 cells by indole-3-carbinol is independent of p53 and bax. Anticancer Res. 19:3199-3203.
2. Chen DZ, Qi M, Auborn KJ, Carter TH. 2001. Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cells and in murine HPV-16 transgenic preneoplastic cervical epithelium. J. Nutr. 131:3294-3302.
3. Bjeldanes LF, Kim JY, Grose KR, Bartholomew JC, Bradfield CA. 1991. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8- tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. U.S.A. 88:9543-9547.
4. Edwards DP, Adams DJ, McGuire WI. 1981. Estrogen regulation of growth and specific protein synthesis in human breast cancer cells in tissue culture. Adv. Exp. Biol. 138:133-149.
5. Newfield L, Bradlow HL, Sepkovic DW, Auborn K. 1998. Estrogen metabolism and the malignant potential of human papillomavirus immortalized keratinocytes. Exp. Biol. Med. 217:322-326.
6. Prall OWJ, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL. 1997. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J. Biol. Chem. 272:10882-10894.
7. Lobenhofer EK, Lee Bennet P, Cable L, Li L, Bushel PR, Afshara CA. 2002. Regulation of DNA replication fork genes by 17b-estradiol. Mol. Endocrinol. 16:1215-1229.
8. Perillo B, Sasso A, Abbondanza C, Palumbo G. 2000. 17β-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via 2 estrogen-responsive elements present in the coding sequence. Mol. Cell. Biol. 8:2890-2901.
9. Jin L et al. 1999. Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice. Cancer Res. 59:3991-3997.
10. Bell MC et al. 2000. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol. Oncol. 78:123-129.
11. Bradlow HL, Michnovicz JJ, Telang NT, Osborne MP. 1991.Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12:1571-1574.
12. Kojima T, Tanaka T, Mori H. 1994. Chemoprevention of spontaneous endometrial cancer in female donyru rats by indole-3-carbinol. Cancer Res. 54:1446-1449.
13. Chen D-Z, Carter TH, Auborn KJ. 2004. Apoptosis in cervical cancer cells: Implications for adjunct anti-estrogen therapy for cervical cancer. Anticancer Res. 24:2649-2656.
14. Chen I, Safe S, Bjeldanes L. 1996. Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem. Pharmacol. 51:1069-1076.
15. Bradlow HL, Telang NT, Sepkovik DW, Osborn MP. 1996. 2-Hydroxyestrone: the "good" estrogen. J. Endrocrinol. 150:S259-265.
16. LaVallee TM et al. 2002. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors α and beta. Cancer Res. 62:3691-3697.
17. Meng Q et al. 2000. Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes. J. Mol. Med. 78:155-165.
18. Fan S et al. 1999. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284:1354-1356.
19. Liu H, Wormke M, Safe SH, Bjeldanes LF. 1994. Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. J. Natl. Cancer Inst. 86:1758-1765.
20. Auborn KJ et al. 2003. Indole-3-carbinol is a negative regulator of estrogen. J. Nutr. 133:2470s-2475s.
21. Evans RM. 1998. The steroid and thyroid hormone receptor superfamily. Science 240:889-895.
22. Katzenellenobogen BS. 1996. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol. Reprod. 54:287-293.
23. Safe S, Krishnan V. 1995. Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression. Arch. Toxicol. Suppl. 17:99-115.
24. Riby J, Chang G, Firestone G, Bjeldanes L. 2000. Ligand-independent activation of estrogen receptor function by 3,3′ diindolylmethane in human breast cancer cells. Biochem. Pharmacol. 60:167-177.
25. Ohtake F et al. 2003. Modulation of oestrogen receptor signaling by association with the activated dioxin receptor. Nature 423:545-550.
26. Chen I, Hsieh T, Thomas T, Safe S. 2001. Identification of estrogen-induced genes downregulated by AhR agonists in MCF-7 breast cancer cells using suppression subtractive hybridization. Gene 262:207-214.
27. Chen I, McDougal A, Wang F, Safe S. 1998. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenisis 19:1631-1639.
28. Chang X et al. 2005. 3,3′-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis 26:771-778.
29. Terry P, Wolk A, Persson I, Magnusson C. 2001. Brassica vegetables and breast cancer risk. J. Am. Med. Assoc. 285:2975-2977.
30. Russo J, Hasan Lareef M, Balogh G, Russo IH. 2003. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. Steroid Biochem. Mol. Biol. 87:1-25.
31. Rogan EG et al. 2003. Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 24:697-702.
32. Jin L et al. 1999. Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice. Cancer Res. 59:3991-3997.
33. Lahita RG, Bradlow HL, Kunkel HG, Fishman J. 1979. Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum. 22:1195-1198.
34. Auborn KJ et al. 2003. Lifespan is prolonged in autoimmune-prone (NZB/NZW) F1 mice fed a diet supplemented with indole-3-carbinol. J. Nutr. 133:3610-3613.
35. Penning TM et al. 2000. Human 3 α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J. 351:67-77.
36. Lewis MJ, Wiebe JP, Heathcote JG. 2004. Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma. BMC Cancer 4:27-38.
37. Phan RT, Dalla-Favera R. 2004. The BCL6 protooncogene suppresses p53 expression in germinal-center B cells. Nature 432:635-639.
38. Yeh PY et al 2006. A pathway for tumor necrosis factor-a-induced Bcl10 nuclear translocation. J. Biol. Chem. 281:167-175.
39. Bouzahzah B et al. 2001. Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol. Med. 7:816-830.
40. Baugher PJ, Krishnamoorthy L, Price JE, Dharmawardhane SF. 2005. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells. Breast Cancer Res. 7:R965-R974.
41. Liang Z et al. 2005. Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res. 65:967-971.
42. Kang H et al. 2005. Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res. 7:R402-R410.
43. Li YM et al. 2004. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6:459-430.
44. Collert MA, Struhl K. 1994. NOT1(CDC39), NOT2(CDC36), NOT3, and NOT4 encode a global-negative regulator of transcription that differentially affects TATA-element utilization. Genes Dev. 8:525-537.
45. Cheng L, Wing HW. (2001a). Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Proc. Natl. Acad. Sci. 98:31-36.
46. Cheng L, Wing HW. (2001b). Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol. 2:research0032.1-0032.11
47. Nebert DW et al. 2000. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response cell cycle control and apoptosis. Biochem. Pharmacol. 59:65-85.
48. Reymann S, Borlak J. 2006. Transcriptome profiling of human hepatocytes treated with Aroclor 1254 reveals transcription factor regulatory networks and clusters of regulated genes. BMC Genomics 7:217-235.
49. Liu S et al. 2006. Aryl hydrocarbon receptor agonists directly activate estrogen receptor α in MCF-7 breast cancer cells. Biol. Chem. 387:1209-1213.